Plasma asymmetric dimethylarginine level and extent of lesion at coronary angiography

Sahinarslan A., Cengel A., Biberoglu G., Hasanoglu A., Turkoglu S., Timurkaynak T.

CORONARY ARTERY DISEASE, cilt.17, sa.7, ss.605-609, 2006 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 17 Sayı: 7
  • Basım Tarihi: 2006
  • Doi Numarası: 10.1097/01.mca.0000236282.81985.e2
  • Dergi Adı: CORONARY ARTERY DISEASE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.605-609
  • Anahtar Kelimeler: coronary artery disease, coronary atherosclerotic score, endothelial dysfunction, L-arginine, nitric oxide, NITRIC-OXIDE SYNTHESIS, ENDOGENOUS INHIBITOR, RISK-FACTOR, L-ARGININE, METABOLITES, ADMA
  • Gazi Üniversitesi Adresli: Hayır

Özet

Background Given that the endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine, can decrease nitric oxide bioavailability and lead to atherosclerosis, its concentration can be a good predictor for coronary artery disease. In this study, we investigated the relationship of plasma asymmetric dimethylarginine concentration with lesion distribution and severity at coronary artery angiography.